These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26929760)

  • 1. Effect of tetanus-diphtheria (Td) vaccine on immune response to hepatitis B vaccine in healthy individuals with insufficient immune response.
    Salehi M; Haghighat A; Salehi H; Taleban R; Salehi M; Kalbasi N; Moafi M; Salehi MM
    J Res Med Sci; 2015 Oct; 20(10):958-62. PubMed ID: 26929760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tetanus-diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-responder Individuals.
    Haghighat A; Moafi M; Sharifian J; Salehi H; Taleban R; Kalbasi N; Salehi M; Salehi MM; Salehi M
    Int J Prev Med; 2016; 7():94. PubMed ID: 27563430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of Tetanus-diphtheria (Td) vaccine impacts on immune response to hepatitis B (HB) vaccine in non-responder dialysis patients.
    Shahidi S; Ghareghani NN; Mortazavi M; Sadeghi S; Adeli R
    J Res Med Sci; 2011 May; 16(5):598-604. PubMed ID: 22091281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative clinical trial in adults.
    Dal-Ré R; Gil A; González A; Lasheras L
    J Clin Pharmacol; 1995 Apr; 35(4):420-5. PubMed ID: 7650233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.
    Moal V; Motte A; Vacher-Coponat H; Tamalet C; Berland Y; Colson P
    J Clin Virol; 2015 Jul; 68():32-6. PubMed ID: 26071332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.
    Lee KH; Shim KS; Lim IS; Chae SA; Yun SW; Lee NM; Choi YB; Yi DY
    BMC Pediatr; 2017 Jul; 17(1):164. PubMed ID: 28705230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
    Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
    Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study.
    Chancharoenthana W; Leelahavanichkul A; Udomkarnjananun S; Wattanatorn S; Avihingsanon Y; Praditpornsilpa K; Tungsanga K; Eiam-Ong S; Townamchai N
    Open Forum Infect Dis; 2019 Jan; 6(1):ofy342. PubMed ID: 30697573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region.
    Dolhain J; Janssens W; Sohn WY; Dindore V; Mukherjee P
    Expert Rev Vaccines; 2019 Sep; 18(9):921-933. PubMed ID: 31328999
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine.
    Lim FS; Han HH; Jacquet JM; Bock HL
    Ann Acad Med Singap; 2007 Oct; 36(10):801-6. PubMed ID: 17987229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.